As of 2025-07-10, the Relative Valuation of Karuna Therapeutics Inc (KRTX) is (154.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 329.83 USD, the upside of Karuna Therapeutics Inc based on Relative Valuation is -146.7%.
The range of the Relative Valuation is (94.12) - (213.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 18.7x | 13.3x |
| Forward P/E multiples | 8.3x - 21.3x | 13.8x |
| Fair Price | (94.12) - (213.03) | (154.03) |
| Upside | -128.5% - -164.6% | -146.7% |
| Date | P/E |